Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05624736

Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep Learning

Conditions: Astrocytoma, Glioblastoma Multiforme, Oligodendroglioma

Sex: All
Ages: 18 Years – 90 Years
Enrollment: 500
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Location: China

Summary

This is a restrospective study to establish a deep learning model based on multi-parametric magnetic resonance imaging scans to predict Grade, histopathologic type and genotype of adult diffuse Glioma.

Eligibility Criteria

Inclusion Criteria:Patients undergoing surgery in Nanjing DrumTower Hospital between 2010.01 and 2022.05 with post-surgery pathological diagnosis of WHO Grade II to IV Adult Diffuse Glioma.Available pre-surgery T1WI, T2WI, T1CE, FLARI and DWI MR sequencesNo pre-surgery anti-tumor therapyExclusion Criteria:Poor image qualityFailed image preprocessingUnavailable pathology data

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05624736). StuddyBuddy aggregates publicly available trial information.